nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxazepam—UGT1A9—Mycophenolic acid—psoriasis	0.148	0.171	CbGbCtD
Oxazepam—UGT2B7—Mycophenolic acid—psoriasis	0.14	0.162	CbGbCtD
Oxazepam—CYP3A43—Dexamethasone—psoriasis	0.0939	0.109	CbGbCtD
Oxazepam—UGT1A9—Mycophenolate mofetil—psoriasis	0.0825	0.0956	CbGbCtD
Oxazepam—UGT2B7—Mycophenolate mofetil—psoriasis	0.0781	0.0904	CbGbCtD
Oxazepam—CYP3A5—Beclomethasone—psoriasis	0.0517	0.0598	CbGbCtD
Oxazepam—CYP3A7—Hydrocortisone—psoriasis	0.022	0.0255	CbGbCtD
Oxazepam—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.022	0.0255	CbGbCtD
Oxazepam—CYP3A7—Cyclosporine—psoriasis	0.0208	0.0241	CbGbCtD
Oxazepam—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.0208	0.0241	CbGbCtD
Oxazepam—CYP3A5—Mycophenolate mofetil—psoriasis	0.0206	0.0238	CbGbCtD
Oxazepam—CYP3A4—Calcitriol—psoriasis	0.018	0.0208	CbGbCtD
Oxazepam—CYP3A5—Hydrocortisone—psoriasis	0.0165	0.0191	CbGbCtD
Oxazepam—CYP3A5—Cyclosporine—psoriasis	0.0156	0.0181	CbGbCtD
Oxazepam—CYP3A4—Methoxsalen—psoriasis	0.014	0.0162	CbGbCtD
Oxazepam—CYP3A7—Dexamethasone—psoriasis	0.0137	0.0158	CbGbCtD
Oxazepam—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.0137	0.0158	CbGbCtD
Oxazepam—CYP3A5—Dexamethasone—psoriasis	0.0103	0.0119	CbGbCtD
Oxazepam—CYP3A4—Cholecalciferol—psoriasis	0.00925	0.0107	CbGbCtD
Oxazepam—CYP3A4—Mycophenolate mofetil—psoriasis	0.00802	0.00929	CbGbCtD
Oxazepam—CYP3A4—Triamcinolone—psoriasis	0.00802	0.00929	CbGbCtD
Oxazepam—CYP3A4—Betamethasone—psoriasis	0.00688	0.00797	CbGbCtD
Oxazepam—CYP3A4—Prednisolone—psoriasis	0.00679	0.00786	CbGbCtD
Oxazepam—CYP3A4—Hydrocortisone—psoriasis	0.00644	0.00745	CbGbCtD
Oxazepam—CYP3A4—Prednisone—psoriasis	0.00641	0.00743	CbGbCtD
Oxazepam—CYP3A4—Cyclosporine—psoriasis	0.00608	0.00704	CbGbCtD
Oxazepam—CYP3A4—Dexamethasone—psoriasis	0.004	0.00464	CbGbCtD
Oxazepam—CYP3A43—Miscellaneous substrates—CYP2S1—psoriasis	0.00224	0.158	CbGpPWpGaD
Oxazepam—CYP3A43—Xenobiotics—CYP2S1—psoriasis	0.00149	0.105	CbGpPWpGaD
Oxazepam—Rash—Clobetasol propionate—psoriasis	0.000687	0.00562	CcSEcCtD
Oxazepam—Dermatitis—Clobetasol propionate—psoriasis	0.000687	0.00562	CcSEcCtD
Oxazepam—Headache—Clobetasol propionate—psoriasis	0.000683	0.00559	CcSEcCtD
Oxazepam—Lethargy—Cyclosporine—psoriasis	0.00068	0.00556	CcSEcCtD
Oxazepam—Stupor—Methotrexate—psoriasis	0.000679	0.00555	CcSEcCtD
Oxazepam—Hallucination—Hydroxyurea—psoriasis	0.000676	0.00553	CcSEcCtD
Oxazepam—Vertigo—Fluocinolone Acetonide—psoriasis	0.000675	0.00553	CcSEcCtD
Oxazepam—Euphoric mood—Triamcinolone—psoriasis	0.00066	0.0054	CcSEcCtD
Oxazepam—Dizziness—Beclomethasone—psoriasis	0.000656	0.00537	CcSEcCtD
Oxazepam—Dizziness—Fluocinonide—psoriasis	0.00065	0.00532	CcSEcCtD
Oxazepam—Diplopia—Mycophenolate mofetil—psoriasis	0.00065	0.00531	CcSEcCtD
Oxazepam—Rash—Beclomethasone—psoriasis	0.000626	0.00512	CcSEcCtD
Oxazepam—Dermatitis—Beclomethasone—psoriasis	0.000625	0.00511	CcSEcCtD
Oxazepam—Headache—Beclomethasone—psoriasis	0.000622	0.00508	CcSEcCtD
Oxazepam—Rash—Fluocinonide—psoriasis	0.00062	0.00507	CcSEcCtD
Oxazepam—Dermatitis—Fluocinonide—psoriasis	0.000619	0.00507	CcSEcCtD
Oxazepam—CYP3A43—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000619	0.0436	CbGpPWpGaD
Oxazepam—Jaundice—Mycophenolic acid—psoriasis	0.000618	0.00506	CcSEcCtD
Oxazepam—Headache—Fluocinonide—psoriasis	0.000616	0.00504	CcSEcCtD
Oxazepam—Oedema—Acitretin—psoriasis	0.000615	0.00503	CcSEcCtD
Oxazepam—Somnolence—Calcitriol—psoriasis	0.000615	0.00503	CcSEcCtD
Oxazepam—Oedema—Fluocinolone Acetonide—psoriasis	0.000614	0.00502	CcSEcCtD
Oxazepam—Body temperature increased—Methoxsalen—psoriasis	0.000613	0.00502	CcSEcCtD
Oxazepam—CYP3A43—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.00061	0.0431	CbGpPWpGaD
Oxazepam—Lethargy—Hydrocortisone—psoriasis	0.000604	0.00494	CcSEcCtD
Oxazepam—CYP3A7—Xenobiotics—CYP2S1—psoriasis	0.0006	0.0423	CbGpPWpGaD
Oxazepam—Euphoric mood—Betamethasone—psoriasis	0.000598	0.0049	CcSEcCtD
Oxazepam—Euphoric mood—Dexamethasone—psoriasis	0.000598	0.0049	CcSEcCtD
Oxazepam—Agranulocytosis—Mycophenolic acid—psoriasis	0.000592	0.00484	CcSEcCtD
Oxazepam—Nausea—Beclomethasone—psoriasis	0.000589	0.00482	CcSEcCtD
Oxazepam—Hypersensitivity—Methoxsalen—psoriasis	0.000572	0.00468	CcSEcCtD
Oxazepam—Hallucination—Mycophenolic acid—psoriasis	0.000567	0.00463	CcSEcCtD
Oxazepam—Gastrointestinal pain—Calcitriol—psoriasis	0.000566	0.00463	CcSEcCtD
Oxazepam—Paraesthesia—Acitretin—psoriasis	0.000552	0.00452	CcSEcCtD
Oxazepam—Somnolence—Acitretin—psoriasis	0.000547	0.00447	CcSEcCtD
Oxazepam—Abdominal pain—Calcitriol—psoriasis	0.000547	0.00447	CcSEcCtD
Oxazepam—Body temperature increased—Calcitriol—psoriasis	0.000547	0.00447	CcSEcCtD
Oxazepam—Dysarthria—Methotrexate—psoriasis	0.000536	0.00438	CcSEcCtD
Oxazepam—Leukopenia—Hydroxyurea—psoriasis	0.00053	0.00433	CcSEcCtD
Oxazepam—Euphoric mood—Prednisone—psoriasis	0.000521	0.00426	CcSEcCtD
Oxazepam—Lethargy—Betamethasone—psoriasis	0.000516	0.00422	CcSEcCtD
Oxazepam—Lethargy—Dexamethasone—psoriasis	0.000516	0.00422	CcSEcCtD
Oxazepam—Dizziness—Methoxsalen—psoriasis	0.000513	0.0042	CcSEcCtD
Oxazepam—Hypersensitivity—Calcitriol—psoriasis	0.00051	0.00417	CcSEcCtD
Oxazepam—Gastrointestinal pain—Acitretin—psoriasis	0.000503	0.00412	CcSEcCtD
Oxazepam—CYP3A43—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000501	0.0354	CbGpPWpGaD
Oxazepam—Jaundice—Cyclosporine—psoriasis	0.0005	0.00409	CcSEcCtD
Oxazepam—Depressed level of consciousness—Methotrexate—psoriasis	0.00049	0.004	CcSEcCtD
Oxazepam—Rash—Methoxsalen—psoriasis	0.000489	0.004	CcSEcCtD
Oxazepam—Dermatitis—Methoxsalen—psoriasis	0.000489	0.004	CcSEcCtD
Oxazepam—Jaundice—Mycophenolate mofetil—psoriasis	0.000488	0.00399	CcSEcCtD
Oxazepam—Body temperature increased—Acitretin—psoriasis	0.000486	0.00398	CcSEcCtD
Oxazepam—Abdominal pain—Acitretin—psoriasis	0.000486	0.00398	CcSEcCtD
Oxazepam—Headache—Methoxsalen—psoriasis	0.000486	0.00398	CcSEcCtD
Oxazepam—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.000485	0.00397	CcSEcCtD
Oxazepam—Oedema—Hydroxyurea—psoriasis	0.000483	0.00395	CcSEcCtD
Oxazepam—Amnesia—Prednisone—psoriasis	0.000469	0.00383	CcSEcCtD
Oxazepam—Vision blurred—Mycophenolic acid—psoriasis	0.000467	0.00382	CcSEcCtD
Oxazepam—Agranulocytosis—Mycophenolate mofetil—psoriasis	0.000467	0.00382	CcSEcCtD
Oxazepam—Tremor—Mycophenolic acid—psoriasis	0.000464	0.0038	CcSEcCtD
Oxazepam—Nausea—Methoxsalen—psoriasis	0.000461	0.00377	CcSEcCtD
Oxazepam—Agitation—Mycophenolic acid—psoriasis	0.000456	0.00373	CcSEcCtD
Oxazepam—Hypersensitivity—Acitretin—psoriasis	0.000453	0.00371	CcSEcCtD
Oxazepam—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000452	0.0037	CcSEcCtD
Oxazepam—Lethargy—Prednisone—psoriasis	0.000449	0.00368	CcSEcCtD
Oxazepam—Hallucination—Mycophenolate mofetil—psoriasis	0.000447	0.00366	CcSEcCtD
Oxazepam—Vertigo—Mycophenolic acid—psoriasis	0.000445	0.00364	CcSEcCtD
Oxazepam—Syncope—Mycophenolic acid—psoriasis	0.000445	0.00364	CcSEcCtD
Oxazepam—Leukopenia—Mycophenolic acid—psoriasis	0.000444	0.00363	CcSEcCtD
Oxazepam—Rash—Calcitriol—psoriasis	0.000436	0.00357	CcSEcCtD
Oxazepam—Loss of consciousness—Mycophenolic acid—psoriasis	0.000436	0.00356	CcSEcCtD
Oxazepam—Dermatitis—Calcitriol—psoriasis	0.000436	0.00356	CcSEcCtD
Oxazepam—CYP3A5—Xenobiotics—CYP2S1—psoriasis	0.000434	0.0306	CbGpPWpGaD
Oxazepam—Headache—Calcitriol—psoriasis	0.000433	0.00354	CcSEcCtD
Oxazepam—Somnolence—Hydroxyurea—psoriasis	0.000429	0.00351	CcSEcCtD
Oxazepam—Nausea—Calcitriol—psoriasis	0.000411	0.00336	CcSEcCtD
Oxazepam—Hallucination—Hydrocortisone—psoriasis	0.000407	0.00333	CcSEcCtD
Oxazepam—Dizziness—Acitretin—psoriasis	0.000407	0.00333	CcSEcCtD
Oxazepam—Dizziness—Fluocinolone Acetonide—psoriasis	0.000406	0.00332	CcSEcCtD
Oxazepam—Oedema—Mycophenolic acid—psoriasis	0.000405	0.00331	CcSEcCtD
Oxazepam—Shock—Mycophenolic acid—psoriasis	0.000398	0.00326	CcSEcCtD
Oxazepam—Rash—Acitretin—psoriasis	0.000388	0.00317	CcSEcCtD
Oxazepam—Dermatitis—Acitretin—psoriasis	0.000388	0.00317	CcSEcCtD
Oxazepam—Rash—Fluocinolone Acetonide—psoriasis	0.000387	0.00316	CcSEcCtD
Oxazepam—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000386	0.00316	CcSEcCtD
Oxazepam—Headache—Acitretin—psoriasis	0.000385	0.00315	CcSEcCtD
Oxazepam—Headache—Fluocinolone Acetonide—psoriasis	0.000384	0.00314	CcSEcCtD
Oxazepam—Body temperature increased—Hydroxyurea—psoriasis	0.000382	0.00312	CcSEcCtD
Oxazepam—Hypotension—Mycophenolic acid—psoriasis	0.000378	0.00309	CcSEcCtD
Oxazepam—Vision blurred—Cyclosporine—psoriasis	0.000378	0.00309	CcSEcCtD
Oxazepam—Tremor—Cyclosporine—psoriasis	0.000376	0.00307	CcSEcCtD
Oxazepam—Lethargy—Methotrexate—psoriasis	0.000376	0.00307	CcSEcCtD
Oxazepam—Agitation—Cyclosporine—psoriasis	0.000369	0.00301	CcSEcCtD
Oxazepam—Tremor—Mycophenolate mofetil—psoriasis	0.000367	0.003	CcSEcCtD
Oxazepam—Nausea—Acitretin—psoriasis	0.000365	0.00299	CcSEcCtD
Oxazepam—Nausea—Fluocinolone Acetonide—psoriasis	0.000364	0.00298	CcSEcCtD
Oxazepam—Paraesthesia—Mycophenolic acid—psoriasis	0.000363	0.00297	CcSEcCtD
Oxazepam—Vertigo—Cyclosporine—psoriasis	0.00036	0.00295	CcSEcCtD
Oxazepam—Somnolence—Mycophenolic acid—psoriasis	0.00036	0.00294	CcSEcCtD
Oxazepam—Agitation—Mycophenolate mofetil—psoriasis	0.00036	0.00294	CcSEcCtD
Oxazepam—Leukopenia—Cyclosporine—psoriasis	0.000359	0.00294	CcSEcCtD
Oxazepam—Hypersensitivity—Hydroxyurea—psoriasis	0.000356	0.00291	CcSEcCtD
Oxazepam—Vertigo—Mycophenolate mofetil—psoriasis	0.000351	0.00288	CcSEcCtD
Oxazepam—Syncope—Mycophenolate mofetil—psoriasis	0.000351	0.00287	CcSEcCtD
Oxazepam—Leukopenia—Mycophenolate mofetil—psoriasis	0.00035	0.00286	CcSEcCtD
Oxazepam—Hallucination—Betamethasone—psoriasis	0.000348	0.00285	CcSEcCtD
Oxazepam—Hallucination—Dexamethasone—psoriasis	0.000348	0.00285	CcSEcCtD
Oxazepam—Ataxia—Methotrexate—psoriasis	0.000346	0.00283	CcSEcCtD
Oxazepam—UGT2B15—Biological oxidations—CYP2S1—psoriasis	0.000345	0.0243	CbGpPWpGaD
Oxazepam—Vision blurred—Prednisolone—psoriasis	0.000344	0.00281	CcSEcCtD
Oxazepam—Loss of consciousness—Mycophenolate mofetil—psoriasis	0.000344	0.00281	CcSEcCtD
Oxazepam—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000331	0.00271	CcSEcCtD
Oxazepam—Vertigo—Prednisolone—psoriasis	0.000328	0.00268	CcSEcCtD
Oxazepam—Oedema—Cyclosporine—psoriasis	0.000327	0.00268	CcSEcCtD
Oxazepam—Syncope—Prednisolone—psoriasis	0.000327	0.00268	CcSEcCtD
Oxazepam—Loss of consciousness—Prednisolone—psoriasis	0.000321	0.00262	CcSEcCtD
Oxazepam—Vertigo—Hydrocortisone—psoriasis	0.00032	0.00262	CcSEcCtD
Oxazepam—Body temperature increased—Mycophenolic acid—psoriasis	0.00032	0.00262	CcSEcCtD
Oxazepam—Abdominal pain—Mycophenolic acid—psoriasis	0.00032	0.00262	CcSEcCtD
Oxazepam—Syncope—Hydrocortisone—psoriasis	0.00032	0.00261	CcSEcCtD
Oxazepam—Dizziness—Hydroxyurea—psoriasis	0.000319	0.00261	CcSEcCtD
Oxazepam—Oedema—Mycophenolate mofetil—psoriasis	0.000319	0.00261	CcSEcCtD
Oxazepam—Shock—Mycophenolate mofetil—psoriasis	0.000314	0.00257	CcSEcCtD
Oxazepam—Loss of consciousness—Hydrocortisone—psoriasis	0.000313	0.00256	CcSEcCtD
Oxazepam—Rash—Hydroxyurea—psoriasis	0.000305	0.00249	CcSEcCtD
Oxazepam—Dermatitis—Hydroxyurea—psoriasis	0.000304	0.00249	CcSEcCtD
Oxazepam—Hallucination—Prednisone—psoriasis	0.000303	0.00248	CcSEcCtD
Oxazepam—Headache—Hydroxyurea—psoriasis	0.000303	0.00248	CcSEcCtD
Oxazepam—Vertigo—Triamcinolone—psoriasis	0.000302	0.00247	CcSEcCtD
Oxazepam—Syncope—Triamcinolone—psoriasis	0.000301	0.00246	CcSEcCtD
Oxazepam—Hypotension—Mycophenolate mofetil—psoriasis	0.000298	0.00244	CcSEcCtD
Oxazepam—Oedema—Prednisolone—psoriasis	0.000298	0.00244	CcSEcCtD
Oxazepam—Loss of consciousness—Triamcinolone—psoriasis	0.000295	0.00241	CcSEcCtD
Oxazepam—Paraesthesia—Cyclosporine—psoriasis	0.000294	0.0024	CcSEcCtD
Oxazepam—Shock—Prednisolone—psoriasis	0.000293	0.0024	CcSEcCtD
Oxazepam—Somnolence—Cyclosporine—psoriasis	0.000291	0.00238	CcSEcCtD
Oxazepam—Oedema—Hydrocortisone—psoriasis	0.000291	0.00238	CcSEcCtD
Oxazepam—Nausea—Hydroxyurea—psoriasis	0.000287	0.00235	CcSEcCtD
Oxazepam—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000287	0.00235	CcSEcCtD
Oxazepam—Shock—Hydrocortisone—psoriasis	0.000286	0.00234	CcSEcCtD
Oxazepam—Somnolence—Mycophenolate mofetil—psoriasis	0.000284	0.00232	CcSEcCtD
Oxazepam—Drowsiness—Methotrexate—psoriasis	0.000284	0.00232	CcSEcCtD
Oxazepam—Oedema—Triamcinolone—psoriasis	0.000274	0.00224	CcSEcCtD
Oxazepam—Vertigo—Betamethasone—psoriasis	0.000274	0.00224	CcSEcCtD
Oxazepam—Vertigo—Dexamethasone—psoriasis	0.000274	0.00224	CcSEcCtD
Oxazepam—Syncope—Dexamethasone—psoriasis	0.000273	0.00223	CcSEcCtD
Oxazepam—Syncope—Betamethasone—psoriasis	0.000273	0.00223	CcSEcCtD
Oxazepam—Hypotension—Hydrocortisone—psoriasis	0.000272	0.00222	CcSEcCtD
Oxazepam—Shock—Triamcinolone—psoriasis	0.000269	0.0022	CcSEcCtD
Oxazepam—Gastrointestinal pain—Cyclosporine—psoriasis	0.000268	0.00219	CcSEcCtD
Oxazepam—Loss of consciousness—Betamethasone—psoriasis	0.000268	0.00219	CcSEcCtD
Oxazepam—Loss of consciousness—Dexamethasone—psoriasis	0.000268	0.00219	CcSEcCtD
Oxazepam—Dizziness—Mycophenolic acid—psoriasis	0.000268	0.00219	CcSEcCtD
Oxazepam—Paraesthesia—Prednisolone—psoriasis	0.000267	0.00219	CcSEcCtD
Oxazepam—CYP3A43—Biological oxidations—CYP2S1—psoriasis	0.000266	0.0188	CbGpPWpGaD
Oxazepam—Agranulocytosis—Methotrexate—psoriasis	0.000265	0.00216	CcSEcCtD
Oxazepam—CYP3A43—Metapathway biotransformation—CYP2S1—psoriasis	0.000263	0.0185	CbGpPWpGaD
Oxazepam—Paraesthesia—Hydrocortisone—psoriasis	0.000261	0.00214	CcSEcCtD
Oxazepam—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000261	0.00214	CcSEcCtD
Oxazepam—Abdominal pain—Cyclosporine—psoriasis	0.000259	0.00212	CcSEcCtD
Oxazepam—Body temperature increased—Cyclosporine—psoriasis	0.000259	0.00212	CcSEcCtD
Oxazepam—Rash—Mycophenolic acid—psoriasis	0.000255	0.00209	CcSEcCtD
Oxazepam—Dermatitis—Mycophenolic acid—psoriasis	0.000255	0.00208	CcSEcCtD
Oxazepam—Headache—Mycophenolic acid—psoriasis	0.000253	0.00207	CcSEcCtD
Oxazepam—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000252	0.00206	CcSEcCtD
Oxazepam—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000252	0.00206	CcSEcCtD
Oxazepam—Vision blurred—Prednisone—psoriasis	0.00025	0.00204	CcSEcCtD
Oxazepam—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000249	0.0176	CbGpPWpGaD
Oxazepam—Oedema—Dexamethasone—psoriasis	0.000249	0.00203	CcSEcCtD
Oxazepam—Oedema—Betamethasone—psoriasis	0.000249	0.00203	CcSEcCtD
Oxazepam—Paraesthesia—Triamcinolone—psoriasis	0.000246	0.00201	CcSEcCtD
Oxazepam—CYP3A7—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000246	0.0173	CbGpPWpGaD
Oxazepam—Shock—Dexamethasone—psoriasis	0.000245	0.002	CcSEcCtD
Oxazepam—Shock—Betamethasone—psoriasis	0.000245	0.002	CcSEcCtD
Oxazepam—Agitation—Prednisone—psoriasis	0.000244	0.00199	CcSEcCtD
Oxazepam—Hypersensitivity—Cyclosporine—psoriasis	0.000241	0.00197	CcSEcCtD
Oxazepam—Nausea—Mycophenolic acid—psoriasis	0.00024	0.00197	CcSEcCtD
Oxazepam—Vertigo—Prednisone—psoriasis	0.000238	0.00195	CcSEcCtD
Oxazepam—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000238	0.00195	CcSEcCtD
Oxazepam—Syncope—Prednisone—psoriasis	0.000238	0.00195	CcSEcCtD
Oxazepam—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000235	0.00192	CcSEcCtD
Oxazepam—Loss of consciousness—Prednisone—psoriasis	0.000233	0.00191	CcSEcCtD
Oxazepam—Hypotension—Betamethasone—psoriasis	0.000232	0.0019	CcSEcCtD
Oxazepam—Hypotension—Dexamethasone—psoriasis	0.000232	0.0019	CcSEcCtD
Oxazepam—Body temperature increased—Hydrocortisone—psoriasis	0.00023	0.00188	CcSEcCtD
Oxazepam—Abdominal pain—Hydrocortisone—psoriasis	0.00023	0.00188	CcSEcCtD
Oxazepam—Paraesthesia—Dexamethasone—psoriasis	0.000223	0.00183	CcSEcCtD
Oxazepam—Paraesthesia—Betamethasone—psoriasis	0.000223	0.00183	CcSEcCtD
Oxazepam—Hypersensitivity—Prednisolone—psoriasis	0.000219	0.0018	CcSEcCtD
Oxazepam—Body temperature increased—Triamcinolone—psoriasis	0.000217	0.00177	CcSEcCtD
Oxazepam—Dizziness—Cyclosporine—psoriasis	0.000216	0.00177	CcSEcCtD
Oxazepam—Oedema—Prednisone—psoriasis	0.000216	0.00177	CcSEcCtD
Oxazepam—Hypersensitivity—Hydrocortisone—psoriasis	0.000214	0.00175	CcSEcCtD
Oxazepam—Shock—Prednisone—psoriasis	0.000213	0.00174	CcSEcCtD
Oxazepam—Dizziness—Mycophenolate mofetil—psoriasis	0.000211	0.00173	CcSEcCtD
Oxazepam—Vision blurred—Methotrexate—psoriasis	0.000209	0.00171	CcSEcCtD
Oxazepam—Rash—Cyclosporine—psoriasis	0.000206	0.00169	CcSEcCtD
Oxazepam—Dermatitis—Cyclosporine—psoriasis	0.000206	0.00169	CcSEcCtD
Oxazepam—Headache—Cyclosporine—psoriasis	0.000205	0.00168	CcSEcCtD
Oxazepam—Gastrointestinal pain—Dexamethasone—psoriasis	0.000203	0.00166	CcSEcCtD
Oxazepam—Gastrointestinal pain—Betamethasone—psoriasis	0.000203	0.00166	CcSEcCtD
Oxazepam—CYP3A7—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000202	0.0142	CbGpPWpGaD
Oxazepam—Hypersensitivity—Triamcinolone—psoriasis	0.000202	0.00165	CcSEcCtD
Oxazepam—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000202	0.0142	CbGpPWpGaD
Oxazepam—Rash—Mycophenolate mofetil—psoriasis	0.000201	0.00165	CcSEcCtD
Oxazepam—Dermatitis—Mycophenolate mofetil—psoriasis	0.000201	0.00165	CcSEcCtD
Oxazepam—Headache—Mycophenolate mofetil—psoriasis	0.0002	0.00164	CcSEcCtD
Oxazepam—Vertigo—Methotrexate—psoriasis	0.000199	0.00163	CcSEcCtD
Oxazepam—Leukopenia—Methotrexate—psoriasis	0.000198	0.00162	CcSEcCtD
Oxazepam—Dizziness—Prednisolone—psoriasis	0.000197	0.00161	CcSEcCtD
Oxazepam—Abdominal pain—Betamethasone—psoriasis	0.000196	0.00161	CcSEcCtD
Oxazepam—Abdominal pain—Dexamethasone—psoriasis	0.000196	0.00161	CcSEcCtD
Oxazepam—Body temperature increased—Betamethasone—psoriasis	0.000196	0.00161	CcSEcCtD
Oxazepam—Body temperature increased—Dexamethasone—psoriasis	0.000196	0.00161	CcSEcCtD
Oxazepam—Nausea—Cyclosporine—psoriasis	0.000194	0.00159	CcSEcCtD
Oxazepam—Paraesthesia—Prednisone—psoriasis	0.000194	0.00159	CcSEcCtD
Oxazepam—Dizziness—Hydrocortisone—psoriasis	0.000192	0.00157	CcSEcCtD
Oxazepam—Nausea—Mycophenolate mofetil—psoriasis	0.00019	0.00155	CcSEcCtD
Oxazepam—Rash—Prednisolone—psoriasis	0.000188	0.00154	CcSEcCtD
Oxazepam—Dermatitis—Prednisolone—psoriasis	0.000188	0.00153	CcSEcCtD
Oxazepam—Headache—Prednisolone—psoriasis	0.000187	0.00153	CcSEcCtD
Oxazepam—Rash—Hydrocortisone—psoriasis	0.000183	0.0015	CcSEcCtD
Oxazepam—Dermatitis—Hydrocortisone—psoriasis	0.000183	0.0015	CcSEcCtD
Oxazepam—Headache—Hydrocortisone—psoriasis	0.000182	0.00149	CcSEcCtD
Oxazepam—Dizziness—Triamcinolone—psoriasis	0.000181	0.00148	CcSEcCtD
Oxazepam—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00018	0.0127	CbGpPWpGaD
Oxazepam—CYP3A5—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000178	0.0125	CbGpPWpGaD
Oxazepam—Gastrointestinal pain—Prednisone—psoriasis	0.000177	0.00145	CcSEcCtD
Oxazepam—Nausea—Prednisolone—psoriasis	0.000177	0.00145	CcSEcCtD
Oxazepam—Nausea—Hydrocortisone—psoriasis	0.000173	0.00141	CcSEcCtD
Oxazepam—Rash—Triamcinolone—psoriasis	0.000173	0.00141	CcSEcCtD
Oxazepam—Dermatitis—Triamcinolone—psoriasis	0.000173	0.00141	CcSEcCtD
Oxazepam—Headache—Triamcinolone—psoriasis	0.000172	0.0014	CcSEcCtD
Oxazepam—Abdominal pain—Prednisone—psoriasis	0.000171	0.0014	CcSEcCtD
Oxazepam—Body temperature increased—Prednisone—psoriasis	0.000171	0.0014	CcSEcCtD
Oxazepam—Hypotension—Methotrexate—psoriasis	0.000169	0.00138	CcSEcCtD
Oxazepam—Dizziness—Betamethasone—psoriasis	0.000164	0.00134	CcSEcCtD
Oxazepam—Dizziness—Dexamethasone—psoriasis	0.000164	0.00134	CcSEcCtD
Oxazepam—Nausea—Triamcinolone—psoriasis	0.000163	0.00133	CcSEcCtD
Oxazepam—Paraesthesia—Methotrexate—psoriasis	0.000162	0.00133	CcSEcCtD
Oxazepam—Somnolence—Methotrexate—psoriasis	0.000161	0.00132	CcSEcCtD
Oxazepam—Hypersensitivity—Prednisone—psoriasis	0.000159	0.0013	CcSEcCtD
Oxazepam—UGT2B7—Biological oxidations—CYP2S1—psoriasis	0.000157	0.0111	CbGpPWpGaD
Oxazepam—Rash—Betamethasone—psoriasis	0.000157	0.00128	CcSEcCtD
Oxazepam—Rash—Dexamethasone—psoriasis	0.000157	0.00128	CcSEcCtD
Oxazepam—Dermatitis—Betamethasone—psoriasis	0.000157	0.00128	CcSEcCtD
Oxazepam—Dermatitis—Dexamethasone—psoriasis	0.000157	0.00128	CcSEcCtD
Oxazepam—Headache—Dexamethasone—psoriasis	0.000156	0.00127	CcSEcCtD
Oxazepam—Headache—Betamethasone—psoriasis	0.000156	0.00127	CcSEcCtD
Oxazepam—UGT2B7—Metapathway biotransformation—CYP2S1—psoriasis	0.000155	0.0109	CbGpPWpGaD
Oxazepam—GABRQ—Orphan transporters—CARM1—psoriasis	0.000154	0.0108	CbGpPWpGaD
Oxazepam—Gastrointestinal pain—Methotrexate—psoriasis	0.000148	0.00121	CcSEcCtD
Oxazepam—Nausea—Betamethasone—psoriasis	0.000148	0.00121	CcSEcCtD
Oxazepam—Nausea—Dexamethasone—psoriasis	0.000148	0.00121	CcSEcCtD
Oxazepam—CYP3A5—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000146	0.0103	CbGpPWpGaD
Oxazepam—Dizziness—Prednisone—psoriasis	0.000143	0.00117	CcSEcCtD
Oxazepam—Body temperature increased—Methotrexate—psoriasis	0.000143	0.00117	CcSEcCtD
Oxazepam—Abdominal pain—Methotrexate—psoriasis	0.000143	0.00117	CcSEcCtD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000142	0.01	CbGpPWpGaD
Oxazepam—Rash—Prednisone—psoriasis	0.000136	0.00112	CcSEcCtD
Oxazepam—Dermatitis—Prednisone—psoriasis	0.000136	0.00112	CcSEcCtD
Oxazepam—Headache—Prednisone—psoriasis	0.000136	0.00111	CcSEcCtD
Oxazepam—Hypersensitivity—Methotrexate—psoriasis	0.000133	0.00109	CcSEcCtD
Oxazepam—Nausea—Prednisone—psoriasis	0.000129	0.00105	CcSEcCtD
Oxazepam—UGT1A9—Biological oxidations—CYP2S1—psoriasis	0.000128	0.009	CbGpPWpGaD
Oxazepam—GABRG3—Orphan transporters—CARM1—psoriasis	0.000127	0.00893	CbGpPWpGaD
Oxazepam—UGT1A9—Metapathway biotransformation—CYP2S1—psoriasis	0.000126	0.00888	CbGpPWpGaD
Oxazepam—GABRB1—Orphan transporters—CARM1—psoriasis	0.000125	0.0088	CbGpPWpGaD
Oxazepam—Dizziness—Methotrexate—psoriasis	0.00012	0.000978	CcSEcCtD
Oxazepam—GABRA6—Orphan transporters—CARM1—psoriasis	0.000118	0.00833	CbGpPWpGaD
Oxazepam—GABRA4—Orphan transporters—CARM1—psoriasis	0.000117	0.00822	CbGpPWpGaD
Oxazepam—Rash—Methotrexate—psoriasis	0.000114	0.000933	CcSEcCtD
Oxazepam—Dermatitis—Methotrexate—psoriasis	0.000114	0.000932	CcSEcCtD
Oxazepam—Headache—Methotrexate—psoriasis	0.000113	0.000927	CcSEcCtD
Oxazepam—Nausea—Methotrexate—psoriasis	0.000107	0.000879	CcSEcCtD
Oxazepam—CYP3A7—Biological oxidations—CYP2S1—psoriasis	0.000107	0.00757	CbGpPWpGaD
Oxazepam—GABRB2—Orphan transporters—CARM1—psoriasis	0.000107	0.00752	CbGpPWpGaD
Oxazepam—CYP3A7—Metapathway biotransformation—CYP2S1—psoriasis	0.000106	0.00746	CbGpPWpGaD
Oxazepam—GABRA5—Orphan transporters—CARM1—psoriasis	0.000104	0.00731	CbGpPWpGaD
Oxazepam—GABRA3—Orphan transporters—CARM1—psoriasis	0.000102	0.00717	CbGpPWpGaD
Oxazepam—GABRA2—Orphan transporters—CARM1—psoriasis	9.99e-05	0.00705	CbGpPWpGaD
Oxazepam—GABRB3—Orphan transporters—CARM1—psoriasis	9.93e-05	0.007	CbGpPWpGaD
Oxazepam—GABRG2—Orphan transporters—CARM1—psoriasis	9.75e-05	0.00688	CbGpPWpGaD
Oxazepam—UGT1A9—PPARA activates gene expression—CARM1—psoriasis	8.91e-05	0.00628	CbGpPWpGaD
Oxazepam—UGT2B7—NRF2 pathway—TGFA—psoriasis	8.74e-05	0.00617	CbGpPWpGaD
Oxazepam—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CARM1—psoriasis	8.72e-05	0.00615	CbGpPWpGaD
Oxazepam—GABRA1—Orphan transporters—CARM1—psoriasis	8.52e-05	0.00601	CbGpPWpGaD
Oxazepam—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	8.37e-05	0.00591	CbGpPWpGaD
Oxazepam—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	8.26e-05	0.00583	CbGpPWpGaD
Oxazepam—CYP3A5—Biological oxidations—CYP2S1—psoriasis	7.75e-05	0.00547	CbGpPWpGaD
Oxazepam—CYP3A5—Metapathway biotransformation—CYP2S1—psoriasis	7.65e-05	0.0054	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—RUNX3—psoriasis	7.25e-05	0.00511	CbGpPWpGaD
Oxazepam—UGT1A9—NRF2 pathway—TGFA—psoriasis	7.1e-05	0.00501	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—NDUFA5—psoriasis	6.93e-05	0.00489	CbGpPWpGaD
Oxazepam—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	6.79e-05	0.00479	CbGpPWpGaD
Oxazepam—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	6.7e-05	0.00472	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	6.11e-05	0.00431	CbGpPWpGaD
Oxazepam—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	6.01e-05	0.00424	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CYP2S1—psoriasis	5.89e-05	0.00416	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—IL13—psoriasis	5.72e-05	0.00404	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—NDUFA5—psoriasis	5.36e-05	0.00378	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	5.28e-05	0.00373	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CYP2S1—psoriasis	4.56e-05	0.00321	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—CP—psoriasis	4.13e-05	0.00291	CbGpPWpGaD
Oxazepam—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	3.96e-05	0.00279	CbGpPWpGaD
Oxazepam—GABRR1—Transmembrane transport of small molecules—CARM1—psoriasis	3.94e-05	0.00278	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—CP—psoriasis	3.94e-05	0.00278	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—CP—psoriasis	3.94e-05	0.00278	CbGpPWpGaD
Oxazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	3.85e-05	0.00271	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—CARM1—psoriasis	3.75e-05	0.00265	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—CARM1—psoriasis	3.75e-05	0.00265	CbGpPWpGaD
Oxazepam—UGT1A9—PPARA activates gene expression—PPARG—psoriasis	3.71e-05	0.00262	CbGpPWpGaD
Oxazepam—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	3.63e-05	0.00256	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—CYP2S1—psoriasis	3.61e-05	0.00254	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—IL10—psoriasis	3.58e-05	0.00252	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	3.56e-05	0.00251	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—NFKBIA—psoriasis	3.41e-05	0.0024	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—CP—psoriasis	3.24e-05	0.00229	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—CP—psoriasis	3.19e-05	0.00225	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—NDUFA5—psoriasis	3.16e-05	0.00223	CbGpPWpGaD
Oxazepam—CYP3A4—Tryptophan metabolism—CAT—psoriasis	3.11e-05	0.00219	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—CARM1—psoriasis	3.09e-05	0.00218	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—CARM1—psoriasis	3.05e-05	0.00215	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—CP—psoriasis	3.02e-05	0.00213	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—CP—psoriasis	2.98e-05	0.0021	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—CARM1—psoriasis	2.88e-05	0.00203	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CARM1—psoriasis	2.88e-05	0.00203	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—CARM1—psoriasis	2.85e-05	0.00201	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—CP—psoriasis	2.73e-05	0.00192	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CYP2S1—psoriasis	2.68e-05	0.00189	CbGpPWpGaD
Oxazepam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.68e-05	0.00189	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—CP—psoriasis	2.65e-05	0.00187	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—CP—psoriasis	2.6e-05	0.00184	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—CARM1—psoriasis	2.6e-05	0.00184	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—NDUFA5—psoriasis	2.57e-05	0.00181	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—CP—psoriasis	2.56e-05	0.0018	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—CP—psoriasis	2.54e-05	0.00179	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—CARM1—psoriasis	2.53e-05	0.00178	CbGpPWpGaD
Oxazepam—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	2.5e-05	0.00176	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—CP—psoriasis	2.49e-05	0.00176	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—CARM1—psoriasis	2.48e-05	0.00175	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—CARM1—psoriasis	2.44e-05	0.00172	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—CARM1—psoriasis	2.42e-05	0.00171	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.39e-05	0.00169	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—CARM1—psoriasis	2.38e-05	0.00168	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—JUN—psoriasis	2.26e-05	0.00159	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CARM1—psoriasis	2.22e-05	0.00157	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CYP2S1—psoriasis	2.18e-05	0.00154	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—CP—psoriasis	2.18e-05	0.00154	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—NFKB1—psoriasis	2.17e-05	0.00153	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—NDUFA5—psoriasis	2.16e-05	0.00152	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—CARM1—psoriasis	2.08e-05	0.00147	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—psoriasis	1.96e-05	0.00138	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—STAT3—psoriasis	1.95e-05	0.00138	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CYP2S1—psoriasis	1.83e-05	0.00129	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—JUN—psoriasis	1.82e-05	0.00128	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CAT—psoriasis	1.77e-05	0.00125	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—NFKB1—psoriasis	1.75e-05	0.00124	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.59e-05	0.00112	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—NDUFA5—psoriasis	1.56e-05	0.0011	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—APOE—psoriasis	1.38e-05	0.000971	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CAT—psoriasis	1.37e-05	0.000965	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—TNF—psoriasis	1.36e-05	0.000961	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CYP2S1—psoriasis	1.33e-05	0.000936	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CARM1—psoriasis	1.31e-05	0.000925	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PPARG—psoriasis	1.2e-05	0.000845	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.14e-05	0.000807	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—IL6—psoriasis	1.1e-05	0.000775	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CARM1—psoriasis	1.07e-05	0.000752	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—APOE—psoriasis	1.06e-05	0.00075	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	9.96e-06	0.000703	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PPARG—psoriasis	9.26e-06	0.000653	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CARM1—psoriasis	8.96e-06	0.000632	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CAT—psoriasis	8.06e-06	0.000569	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—NDUFA5—psoriasis	7.25e-06	0.000512	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CAT—psoriasis	6.55e-06	0.000462	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CARM1—psoriasis	6.48e-06	0.000457	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—APOE—psoriasis	6.27e-06	0.000442	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CYP2S1—psoriasis	6.17e-06	0.000435	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CAT—psoriasis	5.51e-06	0.000389	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PPARG—psoriasis	5.46e-06	0.000385	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—APOE—psoriasis	5.09e-06	0.000359	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PPARG—psoriasis	4.43e-06	0.000313	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—APOE—psoriasis	4.28e-06	0.000302	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CAT—psoriasis	3.98e-06	0.000281	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PPARG—psoriasis	3.73e-06	0.000263	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—APOE—psoriasis	3.1e-06	0.000218	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CARM1—psoriasis	3.01e-06	0.000212	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PPARG—psoriasis	2.7e-06	0.00019	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CAT—psoriasis	1.85e-06	0.000131	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—APOE—psoriasis	1.44e-06	0.000102	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PPARG—psoriasis	1.25e-06	8.84e-05	CbGpPWpGaD
